India saw 62,714 new coronavirus infections in a day, the highest single day rise so far this year, taking the nationwide COVID-19 tally to 1,19,71,624, according to the Union Health Ministry data updated on Sunday.
Registering a steady increase for the 18th day in row, the active cases have increased to 4,86,310 comprising 4.06 percent of the total infections, while the recovery rate has further dropped to 94.58 percent, the data stated.
The 62,714 new cases were reported in a span of 24 hours, the highest since October 16, 2020, while the death toll increased to 1,61,552 with 312 daily new fatalities, the highest in around three months, the data updated at 8 am showed.
The daily death toll of 312 is the highest since December 25, 2020 when 336 new deaths were reported. As many as 63,371 new infections were recorded in a span of 24 hours on October 16.
The number of people who have recuperated from the disease surged to 1,13,23,762, while the case fatality rate stood at 1.35 percent, the data stated.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.
It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.
According to the ICMR, 24,09,50,842 samples have been tested up to March 27 with 11,81,289 samples being tested on Saturday.
(With PTI inputs)